JLJiali Mm Liu

Jiali Mm Liu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jiali Mm Liu has a total of 11 co-authors. Here are the top co-authors by number of shared publications:

  • Huiling Zheng

    Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Zhejiang Chinese Medical University, Xinhua Hospital of Zhejiang Province, Hangzhou, China

    2 shared publications
  • Lihua Jin

    Department of Gynaecology and Obstetrics, The Second Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, China

    2 shared publications
  • Ruilan Mm Li

    Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Zhejiang Chinese Medical University, Xinhua Hospital of Zhejiang Province, Hangzhou, China

    2 shared publications
  • Yi Mm Yang

    Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Zhejiang Chinese Medical University, Xinhua Hospital of Zhejiang Province, Hangzhou, China

    2 shared publications
  • Yunxia Mm Lin

    Department of Gynaecology and Obstetrics, The Second Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, China

    2 shared publications
  • Dexin Mm Hu

    Department of Orthopaedics, Hangzhou Red Cross Hospital, Hangzhou, China

    1 shared publication

Latest Publications

  • Open Access

    Massive pulmonary embolism after cesarean section in a pregnant with occult pneumonia after COVID-19 infection: A case report

    by Huijun Ye, Yi Yang, Ping Zhu, Huiling Zheng, Yunxia Lin, Jiali Liu, Ruilan Li, Lihua Jin

    Rationale: Pregnant and postpartum women have a hypercoagulable state, and COVID-19 infection further heightens the risk of venous thromboembolism, with pulmonary embolism (PE) in COVID-19-infected pregnant women being a global concern. Patient concerns: A 47-year-old pregnant woman with a history of 3 vaginal deliveries and 1 cesarean section, who had a neo-coronavirus infection 29 days ago with rapid symptom resolution, developed asymptomatic massive PE within 24 hours after cesarean section at 38+ weeks of gestation. Diagnoses: Massive PE was diagnosed by computed tomography pulmonary angiography, which showed thromboembolism in multiple parts of the pulmonary arteries, along with pleural effusion and lung inflammation. Cardiac ultrasound revealed mildly elevated pulmonary artery systolic pressure and mild mitral and tricuspid regurgitation. Interventions: Anticoagulation therapy was initially with enoxaparin sodium injection, and the dosage was adjusted. Intravenous anti-infection therapy was also given. After discharge, the patient was switched to rivaroxaban. Compression stockings were used for venous thromboembolism prevention. Outcomes: After 5 months of anticoagulation therapy, the computed tomography pulmonary angiography of the pulmonary artery was completely normalized, but a small amount of interstitial lung lesions still persisted. Lessons: Pregnant women infected with the new coronavirus need close attention during pregnancy and puerperium, especially those with thrombosis risk factors who should receive early anticoagulation. There are many aspects worthy of further exploration, such as the necessity of early pulmonary computed tomography scans and appropriate anticoagulant dosage in pregnant women with COVID-19 infection.


  • Open Access

    Clinical efficacy of Gualou Xiaoyong Decoction and painless lactation manipulation in treating lactation acute mastitis and breast abscess: An observational study

    by Huijun Bm Ye, Dexin Mm Hu, Huiling Bm Zheng, Yi Mm Yang, Yunxia Mm Lin, Jiali Mm Liu, Xi Luo, Ruilan Mm Li, Fengying Mm Hu, Lihua Jin

    Information on the effects of Chinese medicine in the treatment of lactational acute mastitis and breast abscess is limited; thus, we conducted an observational study to analyze the clinical efficacy of Gualou Xiaoyong Decoction combined with painless lactation manipulation in the treatment of lactational acute mastitis and breast abscess. A total of 41 patients with lactational acute mastitis and breast abscess who were treated with Gualou Xiaoyong Decoction and painless lactation manipulation from October 2021 to October 2022 were included in this study. The age, fetal times(primiparous/multiparous), delivery mode (cesarean section/vaginal delivery), onset time, breast lump diameter, skin rash diameter, body temperature, visual analogue score, blood routine, C-reactive protein, procalcitonin, bacterial culture in milk, B ultrasound and other data of these patients were statistically analyzed. After treatment, the breast lump diameter of these patients decreased significantly, the skin rash diameter was reduced or disappeared, the body temperature decreased or returned to a normal range, and the visual analogue score also decreased. Besides, these patients had a decreased total number of white blood cells and a reduced percentage of neutrophils, C-reactive protein, and procalcitonin after treatment. In addition, bacteria in the milk of most patients disappeared, and there was no abnormality in B ultrasonic imaging. Except for 2 patients with breast abscess who stopped breastfeeding on the affected side for 1 day and 3 days respectively, all other patients continued to provide breast milk for their infants, and no adverse reactions were observed in these infants. The combination of Gualou Xiaoyong Decoction and painless lactation manipulation can achieve favorable clinical effects in the treatment of lactational acute mastitis and breast abscess. This combined therapy has good efficacy, short course of treatment, low costs, and great convenience with the avoidance of pain, hospitalization, influence on lactation, breast scar and other adverse outcomes.